Pune, India, Aug. 30, 2022 (GLOBE NEWSWIRE) — global contract development and production organization market the size is projected to reach $278.98 billion by the end of 2026. Mergers and acquisitions are a growing trend among large companies worldwide. According to a report published by Fortune Business Insights, titled “Contract Development and Manufacturing Organization (CDMO) Market Size, Share and Industry Analysis, By Service {By CMO (API, Finished Product {Dosage Forms Solid, Injectable and Others}, and Packaging)} {By CRO (Discovery, Preclinical Trials, Clinical and Laboratory Services)} and Regional Forecast, 2019-2026,” the market was valued at USD 130.80 billion in 2018 and will exhibit a CAGR of 10.0% during the forecast period, 2019-2026.
Request a sample copy of the research report
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contract-development-and-manufacturing-organization-cdmo-outsourcing-market-102502
Industry developments:
February 2019: Jubilant Biosys collaborated with Sanofi to develop small molecule inhibitors for the CNS therapeutic area.
Report field
| Report coverage | The details |
| Forecast period | 2019 to 2026 |
| Forecast period 2019 to 2026 CAGR | 10.0% |
| 2026 Value Projection | 278.98 billion dollars |
| Base year | 2018 |
| Market size in 2018 | 130.8 billion dollars |
| Historical data for | 2015 to 2017 |
| number of pages | 155 |
| Key players | Catalent, Inc., Baxter, Vetter, Recipharm AB, Albany Molecular Research Inc. (AMRI), Thermo Fisher Scientific Inc. (Patheon), Unither, DPT LABORATORIES LTD., NextPharma Technologies |
| Growth drivers | Increasing demand for pharmaceutical products will help growth |
| Asia Pacific to register highest CAGR; Increasing company collaborations will help grow the regional market | |
| Diversified portfolio and growing focus on Mergers & Acquisition to prove leadership position of winning strategy in global market |
Summary of the report:
The contract development and manufacturing organization market is segmented based on factors such as service and geography. The report provides forecast values for the market for the period 2019-2026. Actual figures are obtained from reliable sources. Furthermore, these forecasts are made based on extensive research analysis methods, along with the opinions of experienced market research professionals. The report highlights the latest product launches and labels key innovations in the market. In addition, it highlights the impact of these products on market growth. The competitive landscape is discussed in detail and predictions are made regarding the leading companies and products in the coming years.
Click here to get the short and long term impact of COVID-19 on this market.
Please visit: https://www.fortunebusinessinsights.com/contract-development-and-manufacturing-organization-cdmo-outsourcing-market-102502
Article summary:
A contract development and manufacturing organization (CDMO) helps healthcare companies develop drugs. He is involved in the overall process, from clinical trials to the commercialization and distribution of drugs. Complexities in therapy and lack of in-house manufacturing capabilities will have a positive impact on market growth in the coming years. High investment in CDMOs will bode well for the overall market in the coming years. Moreover, the increasing number of strategic mergers and collaborations will contribute to the growth of the market. The use of advanced technologies in drug development processes will benefit companies operating in the market.
Rapid Acquisition Contract Development and Manufacturing Organization Market
https://www.fortunebusinessinsights.com/checkout-page/102502
Recipharm AB introduces a new fully integrated service platform
Considering the huge potential held by CDMOs, some companies are looking to invest more in the development of newer products. Major investments have yielded some outstanding products in recent years. In May 2019, Recipharm AB announced the launch of a fully integrated service platform for inhalation products. This will include the early stages of products including pre-clinical trials through to commercialization of products. Recipharm’s latest product will generate huge sales and subsequently high revenue for the company. This will not only benefit the company, but will have a positive impact on the growth of the overall market in the coming years.
Asia Pacific to register highest CAGR; Increasing company collaborations will help grow the regional market
The report analyzes ongoing CDMO market trends in North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Among these regions, the market in Asia Pacific will register the highest CAGR in the coming years driven by the increasing number of collaborations and mergers of companies in several countries around the world. The market in North America is predicted to emerge dominant in the coming years, owing to the presence of several well-known companies. As of 2018, the market in North America was valued at $48.72 billion in 2018 and this value is projected to grow further in the coming years.
Get your personalized research report:
https://www.fortunebusinessinsights.com/enquiry/customization/contract-development-and-manufacturing-organization-cdmo-outsourcing-market-102502
Contract Development and Manufacturing Organization Market Segmentations:
| SEgmENTATiON | With service From the CMO
From CRO
|
According to Geography
|
List of companies profiled in the report:
- Catalent, Inc.
- Baxter
- Vet
- Recipharm AB
- Albany Molecular Research Inc . (AMRI)
- Thermo Fisher Scientific Inc. (Patheon)
- Said one
- DPT LABORATORIES LTD.
- NextPharma Technologies
- Others
Do you have any questions? Ask our experts
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/contract-development-and-manufacturing-organization-cdmo-outsourcing-market-102502
Table of Contents
- presentation
- Research Area
- Market segmentation
- Research methodology
- Definitions and assumptions
- Executive Summary
- Market Dynamics
- Market leaders
- Market restrictions
- Market Opportunities
- Key insights
- Key industry developments (mergers, acquisitions and partnerships,)
- Regulatory Scenario for key countries/Regions
- Key market trends
- Map of key services from key players
- Global Contract Development and Manufacturing Organization (CDMO) Market Analysis, Insights and Forecasts, 2015-2026
- Key Findings / Summary
- Market Analysis, Insights and Forecasts – By Service
- CMO
- Production API
- Production of the finished product
- Solid dosage forms
- Injections
- Other (semi-solid/liquid, powder)
- packing
- CRO
- DISCLOSURE
- preclinical
- CLINICAL
- Laboratory Services
- CMO
- Market Analysis, Insights and Forecasts – By Region
- North America
- Europe
- Asia Pacific
- The rest of the world
ToC Continue…!
Frequently asked questions
How much is the contract manufacturing and development services market worth?
According to Fortune Business Insights, the global market was $130.80 billion in 2018 and is projected to reach $278.98 billion by 2026.
What is the main segment in the CDMO market by service?
According to Fortune Business Insights, the CDMO segment is the leading segment in this market by service.
Around us:
Fortune Business Insights™ provides accurate data and innovative corporate analysis, helping organizations of all sizes make the right decisions. We tailor new solutions to our clients, helping them address the various challenges of their businesses. Our goal is to empower them with comprehensive market intelligence, providing a broad overview of the market in which they operate.
Address:
Fortune Business Insights Pvt. Ltd. 9th Floor, Icon Tower, Banner –
Mahalunge Road, Baner, Pune-411045,
Maharashtra, India.
Phone:
USA: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: [email protected]
